Durable complete response rates following radiotherapy and immunotherapy combination in recurrent and metastatic head and neck squamous cell carcinoma: A retrospective single-centre cohort study

Clin Otolaryngol. 2022 Sep;47(5):606-610. doi: 10.1111/coa.13954. Epub 2022 Jul 15.

Authors

Raj Khera^{1

2}, Laura Feeney^{1

3}, Martin Swinton¹, Samuel Rack¹, Andrew Sykes¹, Robert Metcalf¹

Affiliations

¹ Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
² The University of Birmingham, Birmingham, UK.
³ Queen's University Belfast, Belfast, UK.

No abstract available

Keywords: head and neck cancer; immunotherapy; nivolumab; radiotherapy.

MeSH terms

Cohort Studies
Head and Neck Neoplasms* / radiotherapy
Humans
Immunotherapy*
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / therapy
Retrospective Studies
Squamous Cell Carcinoma of Head and Neck / therapy